Marketing Pharmaceuticals 2016

Discuss the complexity of marketing and how to promote pharmaceuticals, biologics, and medical devices in an effective yet compliant manner in an evolving environment.

戻る Agenda

Session 4C: Mock Review: A Regulatory Perspective

Session Chair(s)

Kristina Vlaovic, MPH

Vice President, Regulatory, Safety and Pharmacovigilance

HALOZYME Inc., United States

Join us as we walk through the review of a typical marketing and sales tool. We'll be discussing the merits and potential pitfalls; emphasizing important questions that should be considered and enabling an interactive session tapping into the expertise of the moderators and audience. This session is intended for professionals who have less than three years of experience, but all are welcome. A few of the topics to be discussed: efficacy analyses, safety presentations, disease education

Speaker(s)

Facilitators:

Laura A. Cooper

Sanofi US, United States

Senior Director, Regulatory Affairs Marketed Products, Oncology

Leah Palmer, PharmD

United States

Consultant, Regulatory Promotion